Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 15/20 | 1.00 |
| ▸ | FKBP5 | Q13451 | 6/20 | 0.89 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22451751 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL18448700 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL25501190 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL29672647 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL20136603 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL15764887 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL10111057 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL20791944 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL26508772 | 0.96 | FKBP1A (0.92) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL16975607 | 0.95 | FKBP1A (0.91) | FKBP1AFKBP5FKBP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150168420-A1 | BIOORTHOGONAL CHEMICAL INDUCERS OF REVERSIBLE DIMERIZATION FOR CONTROL OF PROTEIN FUNCTION IN CELLS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150168420-A1 | BIOORTHOGONAL CHEMICAL INDUCERS OF REVERSIBLE DIMERIZATION FOR CONTROL OF PROTEIN FUNCTION IN CELLS | FKBP2, FKBP3, FKBP14 | FKBP1A 4/4885FKBP5 6/4885FKBP4 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.